Abiopharma

Signs $14 Million Agreement to Expand Broadband Internet Access in Peru

Can-Fite: Namodenoson Enhances the Anti-Cancer Effect of Chemotherapy in Pancreatic Cancer. The New Mechanistic Findings Support Can-Fite’s Ongoing Phase IIb Study Design Following Positive Phase IIa Results

Auddia Announces Exclusive Label Partnership with AMG Corp, Making Discovr Radio Its Exclusive Digital Radio Release Channel

Castle Biosciences Approved for Dual Listing on Nasdaq Texas

Otis to Provide More Than 250 Elevators and Escalators to Tianjin 117 Tower, Chinas New Supertall Landmark

Freightos Reports Second Quarter 2026 Results

Visteon Declares Quarterly Dividend of $0.375 Per Share

Fulcrum Therapeutics and Slate Medicines Announce Merger Agreement to Advance Next-Generation Migraine Therapies

GXO Leaders Receive 2026 Women in Supply Chain Awards

NRx Pharmaceuticals (Nasdaq:NRXP) Reports Second Quarter 2026 Financial Results and Provides Corporate Update; Conference Call to be Held on Monday, August 17th at 4:30pm ET

Tilray Medical Accelerates the Commercial Expansion of Tilray Medical-Branded Cannabis Medicines in the UK with First Direct-to-Patient Launch Through Lyphe Clinic and Lyphe Dispensary

Barings Global Short Duration High Yield Fund Announces August 2026 Monthly Distribution of $0.1223 per Share

United Therapeutics Corporation Announces Full Enrollment of the TETON-PPF Study of Inhaled Treprostinil for the Treatment of Progressive Pulmonary Fibrosis

Pulsenmore Receives Second AI Grant Within One Month: Israel Innovation Authority Approves $1.27 Million for SmartScan AI Program

Prairie Operating Co. Announces Second Quarter 2026 Results